CMPX
Compass Therapeutics Inc.
Company Overview
| Mkt Cap | $468.78M | Price | $3.74 |
| Volume | 2.29M | Change | +0.54% |
| P/E Ratio | -9.5 | Open | $3.72 |
| Revenue | $850.0K | Prev Close | $3.72 |
| Net Income | $-49.4M | 52W Range | $1.27 - $4.86 |
| Div Yield | N/A | Target | $12.91 |
| Overall | 59 | Value | 60 |
| Quality | 42 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyCompass Therapeutics Inc. (CMPX) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $3.74 with a market capitalization of $468.78 million. The stock is positioned in the upper portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows CMPX with a volume of 2.29 million shares. The stock opened down 0.00% from yesterday's close of $3.72. Current analyst estimates project earnings of $-0.55 per share for this year, with next year targeting $-0.59.
CMPX demonstrates strong technical indicators based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for CMPX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 245.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:11 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CMPX | $3.74 | +0.5% | 2.29M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Compass Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW